Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT03813199 · COMPLETED
Trial details
- NCT number
- NCT03813199
- Sponsor
- Abivax S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2021-04-27
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.